Katariina Castrén

600 total citations
10 papers, 478 citations indexed

About

Katariina Castrén is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Katariina Castrén has authored 10 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Molecular Biology and 2 papers in Cancer Research. Recurrent topics in Katariina Castrén's work include Cancer-related Molecular Pathways (8 papers), RNA modifications and cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). Katariina Castrén is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), RNA modifications and cancer (2 papers) and Cancer Genomics and Diagnostics (2 papers). Katariina Castrén collaborates with scholars based in Finland and United States. Katariina Castrén's co-authors include Kirsi Vähäkangas, Judith A. Welsh, William P. Bennett, Brunhilde Blömeke, Curtis C. Harris, Michael C.R. Alavanja, Khan Ma, Annamari Ranki, Douglas B. Flieder and Elise D. Bowman and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Katariina Castrén

10 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katariina Castrén Finland 9 247 211 138 91 62 10 478
David C. Christiani United States 12 253 1.0× 123 0.6× 90 0.7× 83 0.9× 55 0.9× 14 463
Vera Ray United States 13 304 1.2× 135 0.6× 77 0.6× 119 1.3× 30 0.5× 21 615
S. Inutsuka Japan 11 188 0.8× 103 0.5× 86 0.6× 117 1.3× 37 0.6× 36 447
S. Anttila Finland 9 325 1.3× 61 0.3× 138 1.0× 125 1.4× 49 0.8× 19 548
Meagan B. Myers United States 17 336 1.4× 185 0.9× 291 2.1× 102 1.1× 76 1.2× 39 681
Mirtha S. Lopez United States 13 305 1.2× 102 0.5× 256 1.9× 86 0.9× 76 1.2× 19 564
Chih‐Yi Chen Taiwan 11 398 1.6× 150 0.7× 133 1.0× 150 1.6× 34 0.5× 20 600
Anna Gasińska Poland 14 135 0.5× 143 0.7× 111 0.8× 189 2.1× 37 0.6× 51 508
Nian Dong China 14 308 1.2× 113 0.5× 92 0.7× 139 1.5× 32 0.5× 32 543
Kazuo Fukutome Japan 16 304 1.2× 134 0.6× 202 1.5× 134 1.5× 61 1.0× 28 668

Countries citing papers authored by Katariina Castrén

Since Specialization
Citations

This map shows the geographic impact of Katariina Castrén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katariina Castrén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katariina Castrén more than expected).

Fields of papers citing papers by Katariina Castrén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katariina Castrén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katariina Castrén. The network helps show where Katariina Castrén may publish in the future.

Co-authorship network of co-authors of Katariina Castrén

This figure shows the co-authorship network connecting the top 25 collaborators of Katariina Castrén. A scholar is included among the top collaborators of Katariina Castrén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katariina Castrén. Katariina Castrén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Vähäkangas, Kirsi, Katariina Castrén, & Judith A. Welsh. (2003). Single-Strand Conformation Polymorphism Analysis of Mutations in Exons 4-8 of the TP53Gene. Humana Press eBooks. 49. 15–27. 5 indexed citations
2.
Vähäkangas, Kirsi, William P. Bennett, Katariina Castrén, et al.. (2001). p53 and K-ras mutations in lung cancers from former and never-smoking women.. PubMed. 61(11). 4350–6. 100 indexed citations
3.
Bennett, William P., Michael C.R. Alavanja, Brunhilde Blömeke, et al.. (1999). Environmental Tobacco Smoke, Genetic Susceptibility, and Risk of Lung Cancer in Never-Smoking Women. JNCI Journal of the National Cancer Institute. 91(23). 2009–2014. 143 indexed citations
4.
Huusko, Pia, Katariina Castrén, Virpi Launonen, et al.. (1999). Germ-Line TP53 Mutations in Finnish Cancer Families Exhibiting Features of the Li-Fraumeni Syndrome and Negative for BRCA1 and BRCA2. Cancer Genetics and Cytogenetics. 112(1). 9–14. 23 indexed citations
5.
Zheng, Aiping, et al.. (1999). p53 status of newly established acute myeloid leukaemia cell lines. British Journal of Cancer. 79(3-4). 407–415. 20 indexed citations
6.
Castrén, Katariina, et al.. (1998). Infrequent p53 mutations in arsenic-related skin lesions.. PubMed. 10(9). 475–82. 33 indexed citations
7.
Castrén, Katariina, et al.. (1998). Absence ofp53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein. International Journal of Cancer. 77(5). 674–678. 25 indexed citations
8.
Welsh, Judith A., Katariina Castrén, & Kirsi Vähäkangas. (1997). Single-strand conformation polymorphism analysis to detect p53 mutations: characterization and development of controls. Clinical Chemistry. 43(12). 2251–2255. 30 indexed citations
9.
Castrén, Katariina, P. Pienimäki, P. Arvela, & Kirsi Vähäkangas. (1996). Metabolites and DNA-binding of carbamazepine and oxcarbazepine in vitro by rat liver microsomes. Human & Experimental Toxicology. 15(7). 577–582. 8 indexed citations
10.
Rämet, Mika, Katariina Castrén, Taina Turpeenniemi-Hujanen, et al.. (1995). p53Protein expression is correlated with benzo[a]pyrene-DNA adducts in carcinoma cell lines. Carcinogenesis. 16(9). 2117–2124. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026